Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Intercellular transfer of a soluble viral superantigen.

Reilly M, Mix D, Reilly AA, Ye XY, Winslow GM.

J Virol. 2000 Sep;74(18):8262-7.

2.

Alternative proteolytic processing of mouse mammary tumor virus superantigens.

Denis F, Shoukry NH, Delcourt M, Thibodeau J, Labrecque N, McGrath H, Munzer JS, Seidah NG, Sékaly RP.

J Virol. 2000 Apr;74(7):3067-73.

3.
4.
5.

Proteolytic processing activates a viral superantigen.

Mix D, Winslow GM.

J Exp Med. 1996 Oct 1;184(4):1549-54.

6.

In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen.

Krummenacher C, Diggelmann H, Acha-Orbea H.

J Virol. 1996 May;70(5):3026-31.

7.

Proteolytic processing is required for viral superantigen activity.

Park CG, Jung MY, Choi Y, Winslow GM.

J Exp Med. 1995 May 1;181(5):1899-904.

8.

Negative-acting factor and superantigen are separable activities of the mouse mammary tumor virus long terminal repeat.

Wintersperger S, Salmons B, Miethke T, Erfle V, Wagner H, Günzburg WH.

Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2745-9.

Supplemental Content

Support Center